Cardiovascular Risk
Essentials of Residual Risk
September 1, 2021
Session 1: Preventing Death & Disability from Atherosclerosis
Featuring: Antonio M. Gotto, MD, FACC, & Raul Santos, MD, PhD
Session 2: Risk Factors: Origin and Development
Featuring: Anne Tybjaerg-Hansen, MD, DMSc, & Peter Wilson, MD
Session 3: Diet and Heart Disease Prevention
Featuring: Alice Lichtenstein, DSc, & Frank Sacks, MD
Session 4: Selecting Lipoprotein Targets of Treatment
Featuring: Chris Packard, CBE, FRSE, & Erik Stroes, MD, PhD
Session 5: Clinical Trials of Statins
Feturing: Eugene Braunwald, MD, & Terje Pedersen, MD
Session 6: Drugs that Can Supplement Statins
Featuring: Erin Donnelly, MD, MHS, & Stephen Nicholls, MBBS, PhD
Session 7: Residual Risk in Obesity and Diabetes
Featuring: Henry Ginsberg, MD, & Lawrence Leiter, MD
Promoting the scientific understanding of atherosclerosis
Newsletters
-
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
-
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.